Legend Biotech Corp at JPMorgan Healthcare Conference Transcript
Great. Welcome. Good morning, everyone. My name is Jess Fye. I'm a biotech analyst at JPMorgan, and we're continuing our 44th Annual Healthcare Conference this morning with Legend. First, you're going to hear a presentation from the company and then we're going to go into a Q&A session. So for all of you in the room, if you want to ask a question, just raise your hands, someone will bring over a microphone. And if you're listening online, you can submit questions to the portal, and I can ask them up here.
So with that out of the way, let me turn it over to Legend's CEO, Ying Huang.
Thank you. Thank you, Jessica, and also thank you, JPMorgan for inviting Legend to be participating in the JPMorgan conference.
This is our standard Safe Harbor disclaimer. I might be making forward-looking statements during my presentation. We undertake no legal obligation to update. For up-to-date information, please refer to our SEC filings and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
